AS1411 can specifically bind to nucleolin, which was highly expressed on the surface of tumor cells, to achieve the purpose of targeted therapy (Destouches et al., 2011; Ding et al., 2011). This evidence concerns the gene NUCLEOLIN and neoplasm.